won molecular tumor board presentation
TRANSCRIPT
![Page 1: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/1.jpg)
The UWCCC/WON Molecular Tumor Board (MTB)
& Registration ProtocolMark E. Burkard MD PhD
WON fall meetingOctober 24, 2015
![Page 2: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/2.jpg)
“I shall never be content until the beneficent influence of the University reaches every home of the state.”
-Charles Van Hise 1904
![Page 3: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/3.jpg)
Launched September 2015UWCCC/WON Molecular Tumor Board
Genetics experts oncologists, pathologists, pharmacologists, pharmacists, cancer researchers
Submit pathology or genomics analysis
Recommendations• Clinical trial• Off-label treatment• Standard treatment
(not targeted)
![Page 4: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/4.jpg)
MTB Chairs & CollaboratorsUWCCCMark Burkard, Dusty Deming & Josh Lang
Research
Jill Kolesar & Anne Traynor
Laboratory Science
Bill Rehrauer & Jennifer Laffin
Pathology
Kristina Matkowskyj & Darya Buehler
WONGundersen Lutheran/LacrosseDr. Ben M. Parsons
St. Vincent/GB OncologyDr. Ruth Warren
![Page 5: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/5.jpg)
What to submit
Clinical case information:• Summary (age, diagnosis, stage, clinical status)• Prior treatments for metastatic cancer• Measurable disease (Y/N)• Sample being tested• Other clinically relevant information (clinical trial eligibility)• Specific question
Specimen and/or molecular data:• Specimen for genomic testing• Genomic test report
![Page 6: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/6.jpg)
What you get
Recommendation:– Clinical trials– Off label use of targeted drugs*– No recommendation
*Recommendations will adhere to an dynamic guidance document that specifies when off-label therapies can be recommended.
![Page 7: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/7.jpg)
MTB vs. Registration Protocol• MTB:
– Expert advice on precision medicine– Commitment to research and using the best
clinical evidence
• Registration Protocol: – Research resource with genomic, clinical and outcome
data – Available to WON members
![Page 8: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/8.jpg)
The WON MTB Workflow
![Page 9: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/9.jpg)
William RehrauerDeaprtment of Pathology
Request UW Pathology review/genomic sequencing
UW Collaborative Genomics CoreUWHC clinical labs
![Page 10: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/10.jpg)
The WON MTB Workflow
![Page 11: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/11.jpg)
The UWCCC Molecular Tumor Board
![Page 12: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/12.jpg)
MTB Meetings
When: 1st and 3rd Thursday of each month 4:30pm
Where: UWCCC or Web-based Conference
Who: Molecular tumor board chairs, trainees, WON collaborators, presenting physicians (optional)
What: Present up to 4 cases, submitted 10 d priorRecommendation returned to treating physician
Cost: $0 … but enroll patient in registry
Cases are de-identified for presentation
![Page 13: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/13.jpg)
The UWCCC MTB Registration Protocol
![Page 14: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/14.jpg)
The MTB Registration Protocol
• To determine the frequency of acceptance of MTB clinical recommendations
• To evaluate effectiveness of precision targeted therapies
![Page 15: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/15.jpg)
The MTB Registration Protocol
• Open to all pts > 18 yo with histologically confirmed solid or hematological malignancy who will have genetic testing
• Signed consent form
• All molecular tumor profiling laboratory reports allowed
![Page 16: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/16.jpg)
Recruitment to the MTB Registration Protocol
• Presented and consented to subjects during regularly scheduled clinic appointments
• Subjects are registered into the UWCCC OnCore Database
• Baseline and follow up clinical, genetic and demographic information collected and stored in OnCore
![Page 17: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/17.jpg)
Recruitment to the MTB &Registration Protocol
Baseline Visit
MTB
Meeting(Days 14-28)
Follow-up Visits while on molecularly-targeted
therapy (if any)b
Annually
Informed Consent X
Collect required data elements X
X
Obtain tumor tissue for genomic testing X
Xc
Order genomic testa X
Xc
Order MTB X
Obtain DNA blood sample for Lang Lab, path slides for
Kolesar Lab, and tissue for Deming Lab (if applicable)d
X
Query Wisconsin Cancer Registry
X
![Page 18: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/18.jpg)
Archived Tumor for the MTB Registration Protocol
• Formalin-fixed paraffin block (preferred)OR
• Five- 5 micron sections placed on positively charged slides
Slides should be labeled in a solvent-resistant manner with subject ID and slide numbers
Allow slides 1 and 3 to air dry for ~24 hrs prior to shipping Slide 2 should be H&E stained and cover slipped prior to
shipping Slides 4 and 5 should be unstained
![Page 19: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/19.jpg)
Blood Samples for the MTB Registration Protocol
Prior to beginning targeted therapy:
• 2-10 mL Cellsave tubes• 2-10mL EDTA tubes Formalin-fixed paraffin block
(preferred)
Samples will be processed for plasma and nucleated cells for analysis of cancer relevant targets and may be used to correlate with mutations observed in tumor tissue
![Page 20: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/20.jpg)
Timelines
• MTB services are now available
• MTB Registration Protocol available early 2016
![Page 21: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/21.jpg)
How to access MTB and testing
![Page 22: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/22.jpg)
UW Collaborative Genomics Core
www.med.wisc.edu/uwcgc• Online Portal Access• Portal Authorization Form• Tests by Method• Tests by Type• Clinical Resources• Genomic Research Resources
![Page 23: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/23.jpg)
The OutReach Online Portal• Hosted by the Wisconsin State Lab of Hygiene
• Used to:Submit Requisition for Genomic TestingRequest MTB ConsultationView and print
UWCGC Test ReportsMTB Recommendations
![Page 24: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/24.jpg)
The OutReach Online Portal
• The OutReach website address is https://www.slh.wisc.edu/elabs/Cytogenetics/
• OutReach can only be accessed by entering a valid user ID and password
![Page 25: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/25.jpg)
The OutReach Online Portal
Click on “Orders”(bottom right)
![Page 26: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/26.jpg)
The OutReach Online Portal
Click on “New Order” (lower left)
![Page 27: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/27.jpg)
The OutReach Online Portal
Submitting MD is selected by clicking “Set Submitter” (alphabetical list of MDs is displayed)
Prior pts and new pts can be accessed here
![Page 28: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/28.jpg)
The OutReach Online Portal
Select “Order Type” (MTB) and select test to be ordered from the pull down MTB
Prior pts and new pts can be accessed here
Click “Place Order”
![Page 30: WON Molecular Tumor Board Presentation](https://reader033.vdocuments.us/reader033/viewer/2022052915/587ceb081a28ab564b8b51f5/html5/thumbnails/30.jpg)